Sex differences in cardiac sarcoidosis
Females presented at an older age and were more symptomatic with higher NYHA class symptoms than males, suggesting that females are presenting or being diagnosed with CS later than males. LVEF, rates of heart block, and ventricular arrhythmias were similar between sexes, suggesting greater heart failure severity in females with CS may be related to greater left ventricular stiffening or worse valvular disease. Differences in survival outcomes were not significant.
Authors
- Nikhil Kolluri (ORCID: https://orcid.org/0000-0001-9613-9637)
- Konstantinos C. Siontis (ORCID: https://orcid.org/0000-0002-6658-0971)
- Katrina Ann Williamson (ORCID: https://orcid.org/0000-0002-6589-9219)
- Panithaya Chareonthaitawee (ORCID: https://orcid.org/0000-0002-3811-8712)
- Suraj Kapa (ORCID: https://orcid.org/0000-0003-2283-4340)
- John P. Bois (ORCID: https://orcid.org/0000-0003-4972-5160)
- Andrew N. Rosenbaum (ORCID: https://orcid.org/0000-0001-9202-0233)
- Omar F. Abou Ezzeddine
- Leslie T. Cooper (ORCID: https://orcid.org/0000-0003-1002-3313)
- Courtney A. Arment (ORCID: https://orcid.org/0000-0002-6975-6530)
- Jenna Davison (ORCID: https://orcid.org/0000-0001-6923-0101)
- John A. Schirger
Institutions
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- Center for Rheumatology (US)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1016/j.ijcha.2025.101777
- Citations
- 1
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Mayo Foundation for Medical Education and Research
- Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston